Effect of dalcetrapib, a CETP modulator, on non-cholesterol sterol markers of cholesterol homeostasis in healthy subjects

Eric J. Niesor, Evelyne Chaput, Andreas Staempfli, Denise Blum, Michael Derks, David Kallend

Index: Atherosclerosis 219(2) , 761-7, (2011)

Full Text: HTML

Abstract

Objective Subjects with high HDL-C show elevated plasma markers of cholesterol absorption and reduced markers of cholesterol synthesis. We evaluated the effect of dalcetrapib, a cholesteryl ester transfer protein modulator, on markers of cholesterol homeostasis in healthy subjects.